DrugPatentWatch Database Preview

DULOXETINE HYDROCHLORIDE Drug Profile

« Back to Dashboard

When do Duloxetine Hydrochloride patents expire, and when can generic versions of Duloxetine Hydrochloride launch?

Duloxetine Hydrochloride is a drug marketed by Actavis Elizabeth, Ajanta Pharma Ltd, Alembic Pharms Ltd, Alkem Labs Ltd, Anchen Pharms, Apotex Inc, Aurobindo Pharma Ltd, Breckenridge Pharm, Dr Reddys Labs Ltd, Hetero Labs Ltd Iii, Inventia Hlthcare, Lupin Ltd, Macleods Pharms Ltd, Prinston Inc, Sun Pharma Global, Teva Pharms Usa, Torrent Pharms Ltd, Zydus Hlthcare, and Zydus Pharms Usa Inc. and is included in nineteen NDAs.

The generic ingredient in DULOXETINE HYDROCHLORIDE is duloxetine hydrochloride. There are forty-one drug master file entries for this compound. Forty-eight suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the duloxetine hydrochloride profile page.

Summary for DULOXETINE HYDROCHLORIDE

US Patents:	0
Applicants:	19
NDAs:	19
Suppliers / Packagers:	43
Bulk Api Vendors:	76
Clinical Trials:	263
Patent Applications:	24
Formulation / Manufacturing:	see details
Drug Prices:	see details
DailyMed Link:	DULOXETINE HYDROCHLORIDE at DailyMed

Pharmacology for DULOXETINE HYDROCHLORIDE

Drug Class	Serotonin and Norepinephrine Reuptake Inhibitor
Mechanism of Action	Norepinephrine Uptake Inhibitors Serotonin Uptake Inhibitors

Medical Subject Heading (MeSH) Categories for DULOXETINE HYDROCHLORIDE

Analgesics

Antidepressive Agents

Dopamine Agents

Serotonin and Noradrenaline Reuptake Inhibitors

Synonyms for DULOXETINE HYDROCHLORIDE

(+)-(S)-N-methyl-.gamma.-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride

(+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propanamine hydrochloride

(+)-(S)-N-METHYL-G-(1-NAPHTHYLOXY)-2-THIOPHENEPROPYLAMINE, HYDROCHLORIDE

(+)-(S)-N-Methyl-gamma-(1-naphthyloxy)-2-thiophenepropylamine hydrochloride

(+)-N-METHYL-3-(1-NAPHTHALENYLOXY)-3-(2-THIENYL)PROPANAMINE HYDROCHLORIDE

(+)-N-methyl-gamma-(1-napthlenloxy)-2-thiophenepropan-amine hydrochloride

(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine hydrochloride

(3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine hydrochloride

(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine hydrochloride

(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine;hydrochloride

(GAMMAS)-N-METHYL-GAMMA-(1-NAPHTHALENYLOXY)-2-THIOPHENEPROPANAMINE HYDROCHLORIDE

(S)-(+)-DULOXETINE HYDROCHLORIDE

(S)-(+)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine hydrochloride

(S)-(+)-N-METHYL-3-(1-NAPHTHALENYLOXY)-3-(2-THIENYL)PROPANAMINE HYDROCHLORIDE

(S)-(+)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine Hydrochloride

(S)-Duloxetine (hydrochloride)

(S)-Duloxetine HCl

(S)-duloxetine hydrochloride

(S)-Duloxetine hydrochloride, >=98% (HPLC)

(S)-METHYL-[3-(NAPHTHALEN-1-YLOXY)-3-THIOPHEN-2-YL-PROPYL]-AMINE HYDROCHLORIDE

(S)-N-METHYL-3-(NAPHTHALEN-1-YLOXY)-3-(THIOPHEN-2-YL)PROPAN-1-AMINE HCL

(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine hydrochloride

(S)-N-METHYL-GAMMA-(1-NAPHTHALENYLOXY)-2-THIOPHENEPROPANAMINE HYDROCHLORIDE

136434-34-9

2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, hydrochloride, (gammaS)-

2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, hydrochloride, (S)-

434D349

9044SC542W

AB0008489

AB2000488

AB23771

AC-924

AC1L1U0N

AC1Q3DMM

AK-72899

AKOS016340453

AN-253

ANW-52464

API0002507

Ariclaim

AX8017673

BFFSMCNJSOPUAY-LMOVPXPDSA-N

BR-72899

C18H19NOS.HCl

C18H20ClNOS

CAS-136434-34-9

CCG-101106

CD0196

CHEBI:31526

CHEMBL1200328

CPD000469136

CS-1993

Cymbalta

Cymbalta (TN)

Cymbalta|||Dulane 20|||LY 248686 HCl

D01179

D4223

DSSTox_CID_26443

DSSTox_GSID_46443

DSSTox_RID_81618

DTXSID9046443

Dulane 20

Duloxetine (hydrochloride)

Duloxetine for system suitability, European Pharmacopoeia (EP) Reference Standard

Duloxetine HCl

Duloxetine HCl (Cymbalta)

Duloxetine hydrochloride (JAN/USAN)

Duloxetine hydrochloride [USAN]

Duloxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)

Duloxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard

Duloxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material

Duloxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard

duloxetine hydrochlorise

EBD2816

EBD29778

FT-0648818

HE222122

HY-B0161A

J10476

KB-50492

KS-1168

LS-172959

LY 248686 HCl

LY-248686

LY-248686 HYDROCHLORIDE

LY-264453

LY248686 HCl

methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine hydrochloride

MFCD06407958

MLS001401452

MLS006010054

MolPort-003-666-661

N-Methyl-gama- -2-thiophenepropanamine

NC00356

NCGC00164559-01

NCGC00164559-03

NSC-744012

NSC-759112

NSC744012

NSC759112

Pharmakon1600-01505387

Q-102508

S-4928

s2084

SAM001246523

SC-00924

SMR000469136

ST24026653

TC-141209

Tox21_112188

Tox21_112188_1

UNII-9044SC542W

Xeristar

US Patents and Regulatory Information for DULOXETINE HYDROCHLORIDE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Prinston Inc	DULOXETINE HYDROCHLORIDE	duloxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	206653-001	May 18, 2017	AB	RX	No	No
Inventia Hlthcare	DULOXETINE HYDROCHLORIDE	duloxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	202336-002	Oct 28, 2015	AB	RX	No	No
Teva Pharms Usa	DULOXETINE HYDROCHLORIDE	duloxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	090783-003	Dec 11, 2013	AB	RX	No	No
Sun Pharma Global	DULOXETINE HYDROCHLORIDE	duloxetine hydrochloride	CAPSULE, DELAYED REL PELLETS;ORAL	090745-002	Dec 11, 2013	AB	RX	No	No